Evidence map›Paper›PMID 22330575›Full record

ArticleComparative medicine2011

Markers for predicting death as an outcome for mice used in infectious disease research.

Rita A Trammell, Linda A Toth

Open access · greenAbstract read
In one paragraph

Article in Comparative medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Vaccines · 2023
    Article
  17. Article
  18. Immune Memory After Respiratory Infection WithFrontiers in cellular and infection microbiology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rita A TrammellDepartment of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
Linda A Toth
Southern Illinois University School of Medicine · US

Funding

Sleep and fatigue during renal disease in miceR01NS040220 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TOTH, LINDA A · 1999 to 2008
$1.8M
BEHAVIORAL AND PHYSIOLOGIC PATHOBIOLOGY OF MICEK26RR017543 · NCRR · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI TOTH, LINDA A · 2002 to 2006
$615k
NCRR NIH HHS K26 RR017543NCRR NIH HHS K26-RR17543NINDS NIH HHS R01 NS040220NINDS NIH HHS R01-NS40220
6 · The paper itself

Abstract

Our goal in this study was to identify objective criteria that could be used to predict an outcome of death in mice subjected to experimental inoculation with infectious organisms. We conducted a retrospective analysis of data collected from 4 independent studies that used several infectious agents (influenza virus strains A/HK/x31[H3N2] and A/Puerto Rico/8/34[H1N1], Streptococcus pneumoniae, and Candida albicans) and mouse strains (A/J, DBA/2J, C57BL/6J, BALB/cByJ). Postinoculation periods ranged from 5 to 21 d, with survival of 30% to 60% of the subjects. In all studies, mice were implanted with either a subcutaneous identification microchip or an intraabdominal radiofrequency transmitter to allow remote measurement of body temperature. After inoculation, mice were weighed and monitored regularly until death occurred or euthanasia was performed. Hypothermia was the most valuable characteristic for distinguishing mice that would survive or succumb to the infection. In addition, weight loss was useful in some of the models. In some cases, the derived measure of the product of temperature and body weight provided the best differentiation of mice in the 2 outcome categories. Therefore, the utility of these measures varied substantially depending on the specific model. This study demonstrates that specific endpoint markers are not uniformly applicable to different models. Rather, such markers should be developed and tested in the context of the model in which they will be used. The use of validated markers for eventual death can signal the need for preemptive euthanasia to alleviate terminal distress and permit timely collection of biologic samples.

Indexed as

BiomarkersAnimal ExperimentationAnimalsAnimals, LaboratoryAnimal WelfareBody TemperatureBody WeightCommunicable DiseasesMicePrognosisRetrospective StudiesTelemetryBiomarkers

Identifiers

PMID22330575
PMCPMC3236690
OpenAlexW9491971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.